Journals
Books
Articles by keyword sPD-1
Key immune checkpoints and their inhibitors in the therapy of bone tumors. Part 1. Signaling system of programmed cell death protein 1 - PD-1/PD-L

A.A. Alferov¹, M.M. Efimova², Yu.B. Kuzmin³, I.N. Kuznetsov4, E.S. Gershtein5, N.E. Kushlinskii6

1–3, 5, 6 N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation  (Moscow, Russia)

4 A.I. Evdokimov Moscow University of Medicine and Dentistry of the Ministry of Health of the Russian Federation (Moscow, Russia)

Clinical implication of the programmed cell death-1 protein PD-1 and its ligand PD-L1 in ovarian cancer (review)

E.S. Gershtein – Dr. Sc. (Biol.), Professor, Leading Research Scientist, Clinical Biochemistry Laboratory, 

N.N. Blokhin National Medical Research Center of Oncology (Moscow)

D.N. Kushlinsky – Ph.D. (Med.), Senior Research Scientist, Department of Radiation and Combined Treatment of Gynecological Diseases, Medical Radiological Scientific Center n.a. A.F. Tsyba – Branch of the Federal State

Budgetary Institution «National Medical Center of Radiology» of the Ministry of Health  of Russian Federation (Moscow)

I.V. Tereshkina – Ph.D. (Med.), Clinical Biochemistry Laboratory, N.N. Blokhin National Medical Research  Center of Oncology (Moscow)

D.O. Utkin – Surgeon, Department of Oncogynecology, Moscow City Oncological Hospital № 62» (Moscow)

N.E. Kushlinskii – Dr.Sc. (Med.), Professor, Academician of RAS, Heard of Clinical Biochemistry Laboratory, N.N. Blokhin National Medical Research Center of Oncology (Moscow)

Clinical significance of immune checkpoint PD-1/PD-L1 colorectal cancer

O.V. Kovaleva1, V.V. Maslennikov2, N.Yu. Sokolov3, M.M. Kontorshchikov4,  A.S. Mochalova5, N.E. Kushlinskii6

1,3,5,6 N.N. Blokhin National Medical Research Center of Oncology (Moscow, Russia)

2 A.I. Evdokimov Moscow University of Medicine and Dentistry  of Ministry of Health of the Russian Federation (Moscow, Russia)

4 Volga Research Medical University (Nizhny Novgorod, Russia)

Content of the soluble form of programmed cell death receptor protein sPD-1 and its ligand sPD-L1 in blood serum of colorectal cancer patients

N.E. Kushlinskii1, V.V. Maslennikov2, E.A. Korotkova3, V.V. Delektorskaya4, E.S. Gershtein5, N.N. Zybina6, A.A. Alferov7, T.N. Zabotina8, Z.Z. Mamedli9, I.S. Stilidi10

1,3–5,7–10 N.N. Blokhin National Medical Research Center of Oncology
of the Ministry of Health of Russia (Moscow, Russia)

2 «Electrontest» (Moscow, Russia)

6 The Federal State Public Enterprise Nikiforov’s All-Russian Center for Emergency and Radiation Medicine
of the Emergencies Ministry of Russia (the Nikiforov’s NRCERM) (St.-Petersburg, Russia)

miRNAs in the regulation of the PD-1/PD-L1 immune checkpoint in ovarian cancer

D.O. Utkin1, V.I. Loginov2, D.N. Kushlinsky3, N.Yu. Sokolov4, A.I. Koltunova5, N.A. Arzhanukhina6, D.V. Rogozhin7, J.G. Pajanidi8, E.A. Braga9

1,4–8 Blokhin National Medical Research Center of Oncology,
Ministry of Health of the Russian Federation (Moscow, Russia)

1 Moscow City Oncology Hospital №62 (Moscow, Russia)

2,9 Institute of General Pathology and Pathophysiology (Moscow, Russia)

3 Institute for advanced training of healthcare professionals of the Ministry of Health
of the Khabarovsk Territory (Khabarovsk, Russia)